Evidence-Based Risk Stratification of TP53-Mutated Myeloid Neoplasms
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Mithun V Shah, Kevin Hung, Anmol Baranwal, Zoe Price, Aref Al-Kali, Carla Toop, Patricia Greipp, Anna Brown, Dariusz Ladon, Dong Chen, Kebede Begna, Monika Kutyna, Danielle Rud, Mark R. Litzow, William J. Hogan, Peter Bardy, Talha Badar, Sharad Kumar, David T Yeung, Mrinal M. Patnaik, James M. Foran, Rong He, Naseema Gangat, Hamish S Scott, Cecilia Y. Arana Yi, Hassan B Alkhateeb, Abhishek A. Mangaonkar, Daniel Thomas, Christopher N. Hahn, Attilio Orazi, Daniel A. Arber, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase
Institutions: Mayo Clinic, Royal Adelaide Hospital, Central Adelaide Local Health Network, South Australia Pathology, The University of Adelaide, Mayo Clinic in Florida, University of South Australia, Centre for Cancer Biology, South Australian Health and Medical Research Institute, Mayo Clinic in Arizona, Texas Tech University, Texas Tech University Health Sciences Center, University of Chicago
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405040177